# Study of Doxorubicin in Patients With Metastatic Breast Cancer/Advanced Ovarian Cancer

> **NCT03055143** · PHASE1 · COMPLETED · sponsor: **Sun Pharma Advanced Research Company Limited** · enrollment: 29 (actual)

## Conditions studied

- Breast Cancer and Ovarian Cancer

## Interventions

- **DRUG:** SPARC-08-038
- **DRUG:** Ref-08-038

## Key facts

- **NCT ID:** NCT03055143
- **Lead sponsor:** Sun Pharma Advanced Research Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09-03
- **Primary completion:** 2009-11-28
- **Final completion:** 2009-11-28
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2021-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03055143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03055143, "Study of Doxorubicin in Patients With Metastatic Breast Cancer/Advanced Ovarian Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03055143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*